CAS:923604-59-5
923604-59-5
CAS号：923604-59-5
品名：司美匹韦Simeprevir
中文别名：(2R,3aR,10Z,11aS,12aR,14aR)-N-(环丙基磺酰基)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-十四氢-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[c]环丙并[g][1,6]二氮杂环十四烯-12a(1H)-甲酰胺;
英文别名：Olysio(TN);(2R,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide;TMC435;TMC-435350;TMC435350;
分子式：C38H47N5O7S2
分子量：749.939
精确质量：749.292
Psa：193.51
UNII号：9WS5RD66HZ
密度：1.38
简介：Simeprevir(formerlyTMC435;tradenamesOlysioandSovriad)isadrugforthetreatmentandcureofhepatitisC.ItwasdevelopedbyMedivirandJohnson&Johnson'spharmaceuticaldivisionJanssenPharmaceutica.IntheUnitedStates,simeprevirisapprovedbytheFoodandDrugAdministrationforuseincombinationwithpeginterferon-alfaandribavirinforhepatitisC.SimeprevirhasbeenapprovedinJapanforthetreatmentofchronichepatitisCinfection,genotype1.
代谢
